Dopaminergic medicines used in the treatment of parkinson’s disease: Risk of Dopamine dysregulation syndrome

Dopaminergic medicines used in the treatment of parkinson’s disease: Risk of Dopamine dysregulation syndrome

2020 Oct

Download latest version
File Type: pdf
Category: Communication To Health Care Professionals
Unit: pharmacovigilance